| Stage | VSNT | % of rev | CMCSA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.6B | 100.00% | $29.3B | 100.00% | CMCSA ×17.82 |
| Gross profit | $994M | 60.46% | $21.8B | 74.35% | CMCSA +13.9pp |
| Operating income | $367M | 22.32% | $5.3B | 18.16% | VSNT +4.2pp |
| Pre-tax income | $323M | 19.65% | $4.4B | 15.18% | VSNT +4.5pp |
| Net income | $211M | 12.83% | $3.4B | 11.48% | VSNT +1.4pp |
| Stage | VSNT | CMCSA | Gap · A − B |
|---|---|---|---|
| Revenue | $1.6B100.00% | $29.3B100.00% | CMCSA ×17.82 |
| Gross profit | 60.46%$994M | 74.35%$21.8B | CMCSA +13.9pp |
| Operating income | 22.32%$367M | 18.16%$5.3B | VSNT +4.2pp |
| Pre-tax income | 19.65%$323M | 15.18%$4.4B | VSNT +4.5pp |
| Net income |
| 12.83%$211M |
| 11.48%$3.4B |
| VSNT +1.4pp |
No shared counterparties.